<DOC>
	<DOCNO>NCT01117051</DOCNO>
	<brief_summary>The study evaluate efficacy , safety tolerability prucalopride 12 week treatment subject age 18 year old chronic non-cancer pain , suffer opioid induced constipation .</brief_summary>
	<brief_title>Prucalopride Effects Subjects With Chronic Non-cancer Pain Suffering From Opioid Induced Constipation</brief_title>
	<detailed_description />
	<mesh_term>Constipation</mesh_term>
	<mesh_term>Stress , Psychological</mesh_term>
	<mesh_term>Analgesics , Opioid</mesh_term>
	<criteria>Inclusion criterion assess screening : 1 . Male nonpregnant , nonbreastfeeding female outpatient â‰¥18 year . 2 . Has chronic pain aetiology ( except cancer pain ) require daily maintenance treatment opioids ; stable daily opioid dose least previous 2 week ; expect remain stable daily dose opioids least 15 week Visit 1 . 3 . Subject suffer OIC ( i.e . secondary chronic opioid use ) . 4 . Subject agree stop his/her laxative treatment willing use rescue medication . Main exclusion criterion assess screening : 1 . Constipation think druginduced ( except opioids ) 2 . Disallowed medication use 3 . Subject chronic therapy chronic constipation prior start opioid therapy 4 . Subject suffer secondary cause chronic constipation .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>Opioid induce constipation/prucalopride chronic non-cancer pain</keyword>
	<keyword>Subjects chronic non-cancer pain suffering OIC</keyword>
</DOC>